2018
Botulinum Toxin in Restless Legs Syndrome—A Randomized Double-Blind Placebo-Controlled Crossover Study
Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum Toxin in Restless Legs Syndrome—A Randomized Double-Blind Placebo-Controlled Crossover Study. Toxins 2018, 10: 401. PMID: 30274305, PMCID: PMC6215171, DOI: 10.3390/toxins10100401.Peer-Reviewed Original ResearchConceptsRestless legs syndromePain scoresCrossover studyLegs syndromePlacebo-controlled crossover studyDouble-blind placeboPatient Global ImpressionVisual analog scalePrevious smaller studiesCommon movement disorderQuality of lifeIncobotulinumtoxin APlacebo groupRLS symptomsAnalog scaleGlobal ImpressionOnabotulinumtoxin ALife QuestionnaireTibialis anteriorBotulinum toxinNormal salineMovement disordersRLS scoresSmall studyFemoris muscleBotulinum toxin in essential hand tremor - A randomized double-blind placebo-controlled study with customized injection approach
Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum toxin in essential hand tremor - A randomized double-blind placebo-controlled study with customized injection approach. Parkinsonism & Related Disorders 2018, 56: 65-69. PMID: 29929813, DOI: 10.1016/j.parkreldis.2018.06.019.Peer-Reviewed Original ResearchConceptsHand weaknessEssential hand tremorDouble-blind placebo-controlled studyEssential tremorAdministration of onabotulinumtoxinASevere hand weaknessPlacebo-controlled studyClinical rating scoresHand tremorRating scoresParkinson's disease tremorIncobotulinumtoxinA injectionsCrossover trialPatients' perceptionsBotulinum toxinTreatment efficacyClinical practiceHand strengthForearm musclesTremor severityClinical scalesTremorWeeksTreatmentInjection
2017
Botulinum Toxin in Parkinson Disease Tremor A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach
Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum Toxin in Parkinson Disease Tremor A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach. Mayo Clinic Proceedings 2017, 92: 1359-1367. PMID: 28789780, DOI: 10.1016/j.mayocp.2017.06.010.Peer-Reviewed Original ResearchConceptsDisease Rating ScaleHand weaknessPatients' perceptionsUnified Parkinson's Disease Rating ScaleParkinson's Disease Rating ScaleAdministration of onabotulinumtoxinASevere hand weaknessUse of onabotulinumtoxinAPatient Global ImpressionClinical rating scoresTreatment of tremorParkinson's disease tremorIncobotulinumtoxinA injectionsCrossover trialGlobal ImpressionGrip strengthRest tremorBotulinum toxinPD tremorPostural tremorTreatment efficacyClinical practiceSignificant improvementEssential tremorHand strength
2016
Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain
Machado D, Kumar A, Jabbari B. Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain. Toxins 2016, 8: 374. PMID: 27983689, PMCID: PMC5198568, DOI: 10.3390/toxins8120374.Peer-Reviewed Original ResearchConceptsChronic low back painLow back painVisual analog scaleOswestry Low Back Pain Disability QuestionnaireAbobotulinum toxin ABack painQuality of lifeToxin APain Disability QuestionnairePatient Global ImpressionLevel of painPrimary outcome measureProportion of respondersStrong analgesic effectAbobotulinum toxinOswestry scorePlacebo groupAnalgesic effectDisability QuestionnaireMore patientsStudy cohortAnalog scaleGlobal ImpressionMultifactorial pathophysiologyPatients' perceptionsIncobotulinum Toxin-A Improves Post-Surgical and Post-Radiation Pain in Cancer Patients
Rostami R, Mittal SO, Radmand R, Jabbari B. Incobotulinum Toxin-A Improves Post-Surgical and Post-Radiation Pain in Cancer Patients. Toxins 2016, 8: 22. PMID: 26771640, PMCID: PMC4728544, DOI: 10.3390/toxins8010022.Peer-Reviewed Original ResearchConceptsVisual analog scaleCancer patientsGlobal ImpressionSite of radiationPoor general conditionPatient Global ImpressionLocation of painIncobotulinum toxin AFocal painAnalgesic medicationPain controlAnalog scaleSkin reactionsToxin ALocal cancerPatientsSignificant improvementPainSurgeryChange ScaleResearch protocolSignificant satisfactionGeneral conditionMedicationsFollow
2012
OnabotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
Mittal S, Machado DG, Jabbari B. OnabotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation. Pain Medicine 2012, 13: 1029-1033. PMID: 22776097, DOI: 10.1111/j.1526-4637.2012.01437.x.Peer-Reviewed Original ResearchConceptsQuality of lifeCancer patientsCancer painLocal treatmentEffect of onabotulinumtoxinAPatient global assessmentAreas of surgeryFocal painMasseter injectionLocal surgeryPain reliefPain areaRepeat injectionsRepeat treatmentPainPatientsSecond injectionSignificant improvementOnabotulinumtoxinAGlobal assessmentSurgeryJaw musclesTreatmentInjectionReliefCrossed synkinesia associated with long-term, intensive tennis playing
Rabin ML, Salardini A, Moghimi N, Jabbari B. Crossed synkinesia associated with long-term, intensive tennis playing. Clinical Neurology And Neurosurgery 2012, 114: 1014-1015. PMID: 22429565, DOI: 10.1016/j.clineuro.2012.01.028.Peer-Reviewed Original Research
2009
Botulinum Neurotoxin-A for Treatment of Refractory Neck Pain: A Randomized, Double-Blind Study
Miller D, Richardson D, Eisa M, Bajwa RJ, Jabbari B. Botulinum Neurotoxin-A for Treatment of Refractory Neck Pain: A Randomized, Double-Blind Study. Pain Medicine 2009, 10: 1012-1017. PMID: 19594841, DOI: 10.1111/j.1526-4637.2009.00658.x.Peer-Reviewed Original ResearchConceptsVisual analog scaleRefractory neck painNeck painExcellent respondersPrimary outcomeMean visual analog scaleAdministration of BoNTEfficacy of BoNTUnits of BoNTChronic neck painPlacebo-controlled studyDouble-blind studyImprovement of ADLBotulinum neurotoxinPlacebo groupAnalgesic effectBotox groupFrequency questionnaireSecondary outcomesPain intensityPain localizationPain QuestionnaireAnalog scaleBlinded studyAnimal studies
2008
Sensory physiology assessed by evoked potentials in survivors of poliomyelitis
Prokhorenko OA, Vasconcelos OM, Lupu VD, Campbell WW, Jabbari B. Sensory physiology assessed by evoked potentials in survivors of poliomyelitis. Muscle & Nerve 2008, 38: 1266-1271. PMID: 18816600, DOI: 10.1002/mus.21093.Peer-Reviewed Original ResearchMeSH KeywordsAfferent PathwaysAgedAged, 80 and overAtrophyBrainCohort StudiesDisability EvaluationDisease ProgressionElectric StimulationElectroencephalographyEvoked Potentials, SomatosensoryFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeural ConductionPoliomyelitisPostpoliomyelitis SyndromeSensation DisordersSensory Receptor CellsSeverity of Illness IndexSpinal CordSurvivorsConceptsMagnetic resonance imagingPolio survivorsLower limb SEPsPatches of atrophySurvivors of poliomyelitisUpper limb SEPsProportion of patientsAbnormal SEPsElectrographic findingsSensory lossMean ageSensory deficitsSpinal cordSensory abnormalitiesSensory impairmentPatientsSensory pathwaysSensory functionSEP studiesResonance imagingPoliomyelitisSurvivorsSensory problemsSEPsFurther studiesTreatment of Painful Limbs/Moving Extremities with Botulinum Toxin Type A Injections
Eisa M, Singer C, Sengun C, Russel A, Jabbari B, Papapetropoulos S. Treatment of Painful Limbs/Moving Extremities with Botulinum Toxin Type A Injections. European Neurology 2008, 60: 104-106. PMID: 18552499, DOI: 10.1159/000138962.Peer-Reviewed Original Research
2007
Physiology of the motor cortex in polio survivors
Lupu VD, Danielian L, Johnsen JA, Vasconcelos OM, Prokhorenko OA, Jabbari B, Campbell WW, Floeter MK. Physiology of the motor cortex in polio survivors. Muscle & Nerve 2007, 37: 177-182. PMID: 17990291, DOI: 10.1002/mus.20913.Peer-Reviewed Original ResearchConceptsCentral motor conduction timeTranscranial magnetic stimulationPolio survivorsMotor cortexPaired-pulse transcranial magnetic stimulationsMotor conduction timeMotor cortex excitabilityPost-polio syndromeTibialis anterior muscleMaximal motorCortex excitabilityTwitch interpolationCentral fatigueCorticospinal systemMaximal contractionHealthy controlsMotor neuronsAnterior muscleConduction timeMagnetic stimulationFunctional changesRecruitment curvesPolioSurvivorsCortex
1993
Contrast agent overdose causing brain retention of contrast, seizures and parkinsonism.
May E, Ling G, Geyer C, Jabbari B. Contrast agent overdose causing brain retention of contrast, seizures and parkinsonism. Neurology 1993, 43: 836-8. PMID: 8469350, DOI: 10.1212/wnl.43.4.836.Peer-Reviewed Original Research